2022
DOI: 10.1002/jeq2.20398
|View full text |Cite
|
Sign up to set email alerts
|

Impacts of the COVID‐19 pandemic on pharmaceuticals in wastewater treated for beneficial reuse: Two case studies in central Pennsylvania

Abstract: During the COVID-19 pandemic, wastewater surveillance was leveraged as a powerful tool for monitoring community-scale health. Further, the well-known persistence of some pharmaceuticals through wastewater treatment plants spurred concerns that increased usage of pharmaceuticals during the pandemic would increase the concentrations in wastewater treatment plant effluent. We collected weekly influent and effluent samples from May 2020 through May 2021 from two wastewater treatment plants in central Pennsylvania,… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 14 publications
(3 citation statements)
references
References 67 publications
(125 reference statements)
0
2
0
Order By: Relevance
“…Economical, effi cient, and environmentally friendly treatment technolo-gies to remove these constituents are imperative in addressing these concerns [11,12]. Moreover, detecting these contaminants in the ambient environment is paramount [13][14][15]. These compounds classifi ed as emerging pollutants (EPs) are directly injected from industries, institutions, and sewage effl uents.…”
Section: Introductionmentioning
confidence: 99%
“…Economical, effi cient, and environmentally friendly treatment technolo-gies to remove these constituents are imperative in addressing these concerns [11,12]. Moreover, detecting these contaminants in the ambient environment is paramount [13][14][15]. These compounds classifi ed as emerging pollutants (EPs) are directly injected from industries, institutions, and sewage effl uents.…”
Section: Introductionmentioning
confidence: 99%
“…Since the Outbreak of the severe acute respiratory coronavirus 2 (COVID- 19) in December 2019, the pandemic has caused a huge pretreatment of solid phase extraction, and then analysis by liquid-mass [10][11][12][13] . Due to the limitation of drug monitoring, there are few clinical test data on these drugs at present, and it is difficult to find the optimal dose.…”
Section: Introductionmentioning
confidence: 99%
“…The worldwide consumption of pharmaceuticals is predicted to increase by 200% by 2030 from the 42 billion defined daily doses in 2015 [ 17 ]. For instance, during the recent COVID-19 pandemic, an unprecedented rise in the usage of drugs and medications was observed [ 18 ]. Generally, PCs tend to encroach on the host environment, such as aqueous media, viz ., surface water, groundwater, cryosphere, and wastewater.…”
Section: Introductionmentioning
confidence: 99%